‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.
Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.

Joshua Peach

‘Volatility is opportunity’: why this manager loves shorting stocks

September 18, 2023
Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.
Read Transcript

Four years ago, Angela Aldrich stood on a stage in New York and told the world her newly minted hedge fund Bayberry Capital Partners was shorting a winemaker listed on the other side of the world, Treasury Wine Estates.

In Australia, investors were shocked. The company, Australia’s largest wine producer, had been on a three-year tear, jumping more than 300 per cent, and was showing little sign of slowing down.

Twelve months after Aldrich stepped off that stage at the Sohn Conference in Manhattan, Treasury Wines’ shares had tumbled 45 per cent.

“Our view wasn’t that TWE was a bad company or that they were doing something nefarious. It had been such a good stock for such a long period, but it started to look like cracks were showing,” Aldrich tells The Australian Financial Review.

“It was so beloved, but you were seeing some things on the balance sheets that didn’t necessarily jibe with what the market was thinking or what had been happening over the past few years

That proved prescient after Treasury Wine Estate downgraded the earnings of its US business the following year, erasing more than $3 billion of market value. It would be the start of a difficult era for the company, worsened by harsh Chinese wine tariffs and the outbreak of COVID-19.

“At some point, everything that’s priced for perfection reaches a point where expectations get too far ahead of themselves,” Aldrich adds.

At the time of the hedge fund manager’s now infamous call on the wine producer, Bayberry Capital was barely a year old, having launched on April Fools’ Day in 2018.

Learning from the ‘tiger cub’

But Aldrich was hardly new to the fund business, having already earned the nickname “Tiger grandcub” after apprenticing under hedge fund legend and famed “Tiger cub” investor John Griffin while at Blue Ridge Capital.

It was from Griffin, whom she worked with for six years, that Aldrich developed her love of betting against a stock. She joined Blue Ridge after stints with Scout Capital and BDT Capital, and at Goldman Sachs as an investment banking analyst after obtaining her MBA from the Stanford Graduate School of Business.

“I definitely caught the short-selling virus from John,” Aldrich says. “There is no cure. I am now that crazy person who is completely attached to the short side.

“John deeply loved the short side, and he just found it incredibly interesting. And he was obviously very good at it. He believed he could make money for investors on both sides of the portfolio, and I just thought that was so interesting.”

Griffin was president at Julian Robertson’s Tiger Management before forming Blue Ridge in 1996. The firm produced annualised returns of 15.4 per cent, consistently beating the benchmark S&P 500 Index across its two decades in operation.

It closed in 2017 and Aldrich launched Bayberry Capital a year later. While the thought of starting a hedge fund in the lead-up to a once-in-a-century pandemic may produce anxiety in some, Aldrich saw it as a stress test for her new venture.

“The past few years have been an entire lifetime of economic cycles. Seeing that type of disruption first-hand when you are managing your own portfolio was a totally different experience,” she says.

“I’m grateful that we got to see all of those things, and an ability to understand what happens to our portfolio in different economic situations.”

It was in that storm of volatility that Aldrich’s mentorship under Griffin really came to the fore.

“The most important lesson that I took from him, especially given what the last four years has been, is his true ability to watch volatility unemotionally,” Aldrich says.

“We need irrational moves in our shorts to get as much juice out of every position as possible. And so it’s been really great for us in this period, no matter which way the market has been moving.”

That doesn’t mean that it’s been painless, however.

One of the hedge fund’s first substantial long positions was Nasdaq-listed Willscot Mobile Mini Holdings, which dived more than 60 per cent from peak to trough during the early months of the pandemic.

“That was a huge use of capital and this wasn’t too long after we launched the fund,” she laments.

But while everything was selling off, the fund, which typically holds around 15 longs and 40 shorts, was buying up companies on the cheap, including online car auction company Copart.

“[It] had been on my fantasy list since I was a junior analyst and had [been] sold off like it was a travel business. Despite that, they actually ended up over-earning during the COVID period”, she says.

Meanwhile, on the other side of the portfolio, Aldrich leant into the short side of the business as the market recovered.

“The subsequent rebound was so violent that we got the opportunity to play existing shorts again, shorts that we’d already covered; we got a second and a third chance.”

More recently, Bayberry made what many would consider a high-stakes bet on UK-listed Burford Capital, a legal finance outfit that had plummeted when a pending court case in Argentina worried the market.

“You’re seeing a market that is very quick to pull the sell trigger,” Aldrich says. “They had this huge outstanding piece of litigation related to about 50 per cent of their stated book value when we started looking at the stock – people thought we were insane.

“You just needed this overhang to go away and people would start buying the stock again. The cherry on top was we thought that overhang was going to go in their favour, and that finally started happening in 2023.”

After winning the case, Burford Capital’s stock recovered rapidly and is now up more than 80 per cent year to date, making it the hedge fund’s best contributor so far this year.

Rooting for the underdogs

The Burford case mimics a lot of the companies that Bayberry picks up. Aldrich, who spends much of her free time volunteering at dog rescue charities, appears to have a soft spot for underdogs in her business life as well.

“We like the weird businesses where there’s no sort of pure-play competitor peer that you can look at,” she said.

Four years after Aldrich shorted Treasury Wine Estates, the stock is still down 25 per cent from the $16-per-share price tag in 2019. Meanwhile, Aldrich’s love of shorts has only grown.

“The reason the short side is so interesting to me personally is when you have high conviction that you’re seeing the cracks in a short today, it tends to be quicker for that information to reach the broader investment community and result in a share price decline,” she says. “I think there is a bad habit going around of viewing volatility as risk. There’s risk in everything. Volatility is the opportunity.”

Angela Aldrich will join 10 other portfolio managers to speak at Sohn Hearts & Minds at the Sydney Opera House on November 17. All profits will support Australian medical research organisations.

The Australian Financial Review is a media partner for the event.

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on 18 September 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Four years ago, Angela Aldrich stood on a stage in New York and told the world her newly minted hedge fund Bayberry Capital Partners was shorting a winemaker listed on the other side of the world, Treasury Wine Estates.

In Australia, investors were shocked. The company, Australia’s largest wine producer, had been on a three-year tear, jumping more than 300 per cent, and was showing little sign of slowing down.

Twelve months after Aldrich stepped off that stage at the Sohn Conference in Manhattan, Treasury Wines’ shares had tumbled 45 per cent.

“Our view wasn’t that TWE was a bad company or that they were doing something nefarious. It had been such a good stock for such a long period, but it started to look like cracks were showing,” Aldrich tells The Australian Financial Review.

“It was so beloved, but you were seeing some things on the balance sheets that didn’t necessarily jibe with what the market was thinking or what had been happening over the past few years

That proved prescient after Treasury Wine Estate downgraded the earnings of its US business the following year, erasing more than $3 billion of market value. It would be the start of a difficult era for the company, worsened by harsh Chinese wine tariffs and the outbreak of COVID-19.

“At some point, everything that’s priced for perfection reaches a point where expectations get too far ahead of themselves,” Aldrich adds.

At the time of the hedge fund manager’s now infamous call on the wine producer, Bayberry Capital was barely a year old, having launched on April Fools’ Day in 2018.

Learning from the ‘tiger cub’

But Aldrich was hardly new to the fund business, having already earned the nickname “Tiger grandcub” after apprenticing under hedge fund legend and famed “Tiger cub” investor John Griffin while at Blue Ridge Capital.

It was from Griffin, whom she worked with for six years, that Aldrich developed her love of betting against a stock. She joined Blue Ridge after stints with Scout Capital and BDT Capital, and at Goldman Sachs as an investment banking analyst after obtaining her MBA from the Stanford Graduate School of Business.

“I definitely caught the short-selling virus from John,” Aldrich says. “There is no cure. I am now that crazy person who is completely attached to the short side.

“John deeply loved the short side, and he just found it incredibly interesting. And he was obviously very good at it. He believed he could make money for investors on both sides of the portfolio, and I just thought that was so interesting.”

Griffin was president at Julian Robertson’s Tiger Management before forming Blue Ridge in 1996. The firm produced annualised returns of 15.4 per cent, consistently beating the benchmark S&P 500 Index across its two decades in operation.

It closed in 2017 and Aldrich launched Bayberry Capital a year later. While the thought of starting a hedge fund in the lead-up to a once-in-a-century pandemic may produce anxiety in some, Aldrich saw it as a stress test for her new venture.

“The past few years have been an entire lifetime of economic cycles. Seeing that type of disruption first-hand when you are managing your own portfolio was a totally different experience,” she says.

“I’m grateful that we got to see all of those things, and an ability to understand what happens to our portfolio in different economic situations.”

It was in that storm of volatility that Aldrich’s mentorship under Griffin really came to the fore.

“The most important lesson that I took from him, especially given what the last four years has been, is his true ability to watch volatility unemotionally,” Aldrich says.

“We need irrational moves in our shorts to get as much juice out of every position as possible. And so it’s been really great for us in this period, no matter which way the market has been moving.”

That doesn’t mean that it’s been painless, however.

One of the hedge fund’s first substantial long positions was Nasdaq-listed Willscot Mobile Mini Holdings, which dived more than 60 per cent from peak to trough during the early months of the pandemic.

“That was a huge use of capital and this wasn’t too long after we launched the fund,” she laments.

But while everything was selling off, the fund, which typically holds around 15 longs and 40 shorts, was buying up companies on the cheap, including online car auction company Copart.

“[It] had been on my fantasy list since I was a junior analyst and had [been] sold off like it was a travel business. Despite that, they actually ended up over-earning during the COVID period”, she says.

Meanwhile, on the other side of the portfolio, Aldrich leant into the short side of the business as the market recovered.

“The subsequent rebound was so violent that we got the opportunity to play existing shorts again, shorts that we’d already covered; we got a second and a third chance.”

More recently, Bayberry made what many would consider a high-stakes bet on UK-listed Burford Capital, a legal finance outfit that had plummeted when a pending court case in Argentina worried the market.

“You’re seeing a market that is very quick to pull the sell trigger,” Aldrich says. “They had this huge outstanding piece of litigation related to about 50 per cent of their stated book value when we started looking at the stock – people thought we were insane.

“You just needed this overhang to go away and people would start buying the stock again. The cherry on top was we thought that overhang was going to go in their favour, and that finally started happening in 2023.”

After winning the case, Burford Capital’s stock recovered rapidly and is now up more than 80 per cent year to date, making it the hedge fund’s best contributor so far this year.

Rooting for the underdogs

The Burford case mimics a lot of the companies that Bayberry picks up. Aldrich, who spends much of her free time volunteering at dog rescue charities, appears to have a soft spot for underdogs in her business life as well.

“We like the weird businesses where there’s no sort of pure-play competitor peer that you can look at,” she said.

Four years after Aldrich shorted Treasury Wine Estates, the stock is still down 25 per cent from the $16-per-share price tag in 2019. Meanwhile, Aldrich’s love of shorts has only grown.

“The reason the short side is so interesting to me personally is when you have high conviction that you’re seeing the cracks in a short today, it tends to be quicker for that information to reach the broader investment community and result in a share price decline,” she says. “I think there is a bad habit going around of viewing volatility as risk. There’s risk in everything. Volatility is the opportunity.”

Angela Aldrich will join 10 other portfolio managers to speak at Sohn Hearts & Minds at the Sydney Opera House on November 17. All profits will support Australian medical research organisations.

The Australian Financial Review is a media partner for the event.

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on 18 September 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by Australian Financial Review, published on Sep 18, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Daniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: Bloomberg
October 23, 2023

Dan Loeb to headline Sohn Hearts & Minds

Famed hedge fund manager Dan Loeb has been named as one of the headline acts for next month’s Sohn Hearts & Minds philanthropic investment conference to be held in Sydney.

Read More
Ravi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn Licht
October 23, 2023

US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

Read More
October 18, 2023

Two small caps: Propel Funeral Services (ASX: PFP) and Clarity Pharmaceuticals (ASX: CU6)

Get to know our 2023 Conference Fund Manager Rikki Bannan of IFM Investors who recently featured on the Equity Mates Media podcast.

Read More
October 16, 2023

How this hedge fund pulled off 2023’s ‘big short’

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.

Read More
IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.
October 10, 2023

Beware the pitfalls of investing in healthcare, says IFM boss

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn’t necessarily proven to be the case,” she says in an interview ahead of her appearance at the Sohn Hearts & Minds Conference 2023.

Read More
October 6, 2023

Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.

Read More
September 15, 2023

Top fund managers share 11 stock picks for the long term

After a dramatic earnings season, fund managers, including Jessica Farr-Jones of Regal Funds and Kieran Moore of Munro Partners (HM1 Core Fund Managers), have shared some of their top picks for long-term growth.

Read More
September 11, 2023

Investors Sweeten On Hedge Funds As Rates Climb

After a decade of easy money pushing equity markets in one direction, Wall Street hedge fund manager Ricky Sandler says the return of volatility and higher interest rates is seeing money return to long-short strategies.

Read More
Eminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John Feder
September 11, 2023

Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.

Read More
Barrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter Rae
September 11, 2023

Top Ny Stock Picker Warns Inflation To Remain Above Pre-Covid Levels

Influential New York hedge fund manager Ricky Sandler of Eminence Capital returns for the 2023 Sohn Hearts & Minds Conference in Sydney and says no one is focused on picking interesting, idiosyncratic stocks.

Read More
August 4, 2023

New Relic

New Relic was pitched by Ricky Sandler of Eminence Capital at the 2022 Sohn Hearts & Minds Conference.

Read More
June 18, 2023

Investors can’t agree how to value the world’s hottest stock

Despite mixed investor opinions, Munro Partners (Core Fund Manager) remains a strong believer in Nvidia. They are standing firm in their investment and still consider it a solid buy.

Read More
June 8, 2023

Stock pickers bet the field in slowing domestic market

Fund managers have batted away fears of an inflation-led recession, with Qantas, Seven Group and Treasury Wines named among the best investments by Australia’s top stock pickers.

Read More
March 27, 2023

The imaginary nepotism that drives Carsales global growth

The long-term approach of Carsales (2022 Conference stock pick) and its CEO Cameron McIntyre has delivered big gains for investors. He reveals his secret to staying strategic.

Read More
March 12, 2023

Jun Bei Liu is not giving up on the China reopening theme

Tribeca’s Jun Bei Liu says China’s reopening is only getting started, and names five ASX stocks set to benefit.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.